CRISPR-Based Multiplex Detection of Human Papillomaviruses for One-Pot Point-of-Care Diagnostics
ACS Synthetic Biology · 15.03.2024 · 13 (3) · 837-850
DOI: 10.1021/acssynbio.3c00655 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Synthetic Biology, online erschienen am 13.02.2024. Verfasst von Ahmed Ghouneimy und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Genome Engineering and Synthetic Biology, Division of Biological Sciences, 4700 King Abdullah University of Science and Technology, Th…. Hauptthemen laut MEDLINE: Papillomavirus Infections, Uterine Cervical Neoplasms. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Abdullah University of Science and Technology.
Abstract (Originalsprache)
The World Health Organization's global initiative toward eliminating high-risk Human Papillomavirus (hrHPV)-related cancers recommends DNA testing over visual inspection in all settings for primary cancer screening and HPV eradication by 2100. However, multiple hrHPV types cause different types of cancers, and there is a pressing need for an easy-to-use, multiplex point-of-care diagnostic platform for detecting different hrHPV types. Recently, CRISPR-Cas systems have been repurposed for point-of-care detection. Here, we established a CRISPR-Cas multiplexed diagnostic assay (CRISPRD) to detect cervical cancer-causing hrHPVs in one reaction (one-pot assay). We harnessed the compatibility of thermostable AapCas12b, TccCas13a, and HheCas13a nucleases with isothermal amplification and successfully detected HPV16 and HPV18, along with an internal control in a single-pot assay with a limit of detection of 10 copies and 100% specificity. This platform offers a rapid and practical solution for the multiplex detection of hrHPVs, which may facilitate large-scale hrHPV point-of-care screening. Furthermore, the CRISPRD platform programmability enables it to be adapted for the multiplex detection of any two nucleic acid biomarkers as well as internal control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Laboratory for Genome Engineering and Synthetic Biology, Division of Biological Sciences, 4700 King Abdullah University of Science and Technology, Thuwal 23955-6900, Saudi Arabia.
- Division of Biological and Biomedical Sciences, College of Health and Life Sciences, Hamad Bin Khalifa University, Education City, Qatar Foundation, P.O. Box: 34110 Doha, Qatar.
ORCID-Profile: Zahir Ali, Mustapha Aouida, Magdy Mahfouz
Förderung
- King Abdullah University of Science and Technology
Zitieren
APA
Ghouneimy, A., Ali, Z., Aman, R., Jiang, W., Aouida, M., & Mahfouz, M. (2024). CRISPR-Based Multiplex Detection of Human Papillomaviruses for One-Pot Point-of-Care Diagnostics. ACS Synthetic Biology, 13(3), 837-850. https://doi.org/10.1021/acssynbio.3c00655
Vancouver
Ghouneimy A, Ali Z, Aman R, Jiang W, Aouida M, Mahfouz M. CRISPR-Based Multiplex Detection of Human Papillomaviruses for One-Pot Point-of-Care Diagnostics. ACS Synthetic Biology. 2024;13(3):837-850. doi:10.1021/acssynbio.3c00655
BibTeX
@article{Ghouneimy2024,
author = {Ghouneimy, Ahmed and Ali, Zahir and Aman, Rashid and Jiang, Wenjun and Aouida, Mustapha and Mahfouz, Magdy},
title = {CRISPR-Based Multiplex Detection of Human Papillomaviruses for One-Pot Point-of-Care Diagnostics},
journal = {ACS Synthetic Biology},
year = {2024},
volume = {13},
number = {3},
pages = {837--850},
doi = {10.1021/acssynbio.3c00655}
}
EUVIMED